Synthesis and biological evaluation of novel GSK-3β inhibitors as anticancer agents

Min Jeong Choi, Da Won Oh, Jae Wan Jang, Yong Seo Cho, Seon Hee Seo, Kyu-Sung Jeong, Soo Young Ko, Ae Nim Pae

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A series of isoxazol-indolin-2-one was designed for GSK-3β inhibitors as novel anticancer agents based on their binding mode analysis in GSK-3β crystal structure. Total 21 compounds were synthesized and evaluated for their inhibitory activity against two tumor cell lines (DU145 and HT29). Most of the synthesized compounds were potent with above 80% inhibitory activity at 100 μM, and several compounds were examined for inhibitory activity against GSK-3β. Among them, 15(Z) (R 1 =H, R 2 =3-Cl-phenyl) was most active with 78% inhibition of tumor cell line (HT29) at 20 μM and 72% inhibition of GSK-3β at 20 μM.

Original languageEnglish
Pages (from-to)2015-2020
Number of pages6
JournalBulletin of the Korean Chemical Society
Volume32
Issue number6
DOIs
Publication statusPublished - 2011 Jun 20

Fingerprint

Glycogen Synthase Kinase 3
Antineoplastic Agents
Tumors
Cells
Crystal structure

All Science Journal Classification (ASJC) codes

  • Chemistry(all)

Cite this

Choi, Min Jeong ; Oh, Da Won ; Jang, Jae Wan ; Cho, Yong Seo ; Seo, Seon Hee ; Jeong, Kyu-Sung ; Ko, Soo Young ; Pae, Ae Nim. / Synthesis and biological evaluation of novel GSK-3β inhibitors as anticancer agents. In: Bulletin of the Korean Chemical Society. 2011 ; Vol. 32, No. 6. pp. 2015-2020.
@article{ef854ab22ec74d4ea418afe85cbe45e7,
title = "Synthesis and biological evaluation of novel GSK-3β inhibitors as anticancer agents",
abstract = "A series of isoxazol-indolin-2-one was designed for GSK-3β inhibitors as novel anticancer agents based on their binding mode analysis in GSK-3β crystal structure. Total 21 compounds were synthesized and evaluated for their inhibitory activity against two tumor cell lines (DU145 and HT29). Most of the synthesized compounds were potent with above 80{\%} inhibitory activity at 100 μM, and several compounds were examined for inhibitory activity against GSK-3β. Among them, 15(Z) (R 1 =H, R 2 =3-Cl-phenyl) was most active with 78{\%} inhibition of tumor cell line (HT29) at 20 μM and 72{\%} inhibition of GSK-3β at 20 μM.",
author = "Choi, {Min Jeong} and Oh, {Da Won} and Jang, {Jae Wan} and Cho, {Yong Seo} and Seo, {Seon Hee} and Kyu-Sung Jeong and Ko, {Soo Young} and Pae, {Ae Nim}",
year = "2011",
month = "6",
day = "20",
doi = "10.5012/bkcs.2011.32.6.2015",
language = "English",
volume = "32",
pages = "2015--2020",
journal = "Bulletin of the Korean Chemical Society",
issn = "0253-2964",
publisher = "Korean Chemical Society",
number = "6",

}

Synthesis and biological evaluation of novel GSK-3β inhibitors as anticancer agents. / Choi, Min Jeong; Oh, Da Won; Jang, Jae Wan; Cho, Yong Seo; Seo, Seon Hee; Jeong, Kyu-Sung; Ko, Soo Young; Pae, Ae Nim.

In: Bulletin of the Korean Chemical Society, Vol. 32, No. 6, 20.06.2011, p. 2015-2020.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Synthesis and biological evaluation of novel GSK-3β inhibitors as anticancer agents

AU - Choi, Min Jeong

AU - Oh, Da Won

AU - Jang, Jae Wan

AU - Cho, Yong Seo

AU - Seo, Seon Hee

AU - Jeong, Kyu-Sung

AU - Ko, Soo Young

AU - Pae, Ae Nim

PY - 2011/6/20

Y1 - 2011/6/20

N2 - A series of isoxazol-indolin-2-one was designed for GSK-3β inhibitors as novel anticancer agents based on their binding mode analysis in GSK-3β crystal structure. Total 21 compounds were synthesized and evaluated for their inhibitory activity against two tumor cell lines (DU145 and HT29). Most of the synthesized compounds were potent with above 80% inhibitory activity at 100 μM, and several compounds were examined for inhibitory activity against GSK-3β. Among them, 15(Z) (R 1 =H, R 2 =3-Cl-phenyl) was most active with 78% inhibition of tumor cell line (HT29) at 20 μM and 72% inhibition of GSK-3β at 20 μM.

AB - A series of isoxazol-indolin-2-one was designed for GSK-3β inhibitors as novel anticancer agents based on their binding mode analysis in GSK-3β crystal structure. Total 21 compounds were synthesized and evaluated for their inhibitory activity against two tumor cell lines (DU145 and HT29). Most of the synthesized compounds were potent with above 80% inhibitory activity at 100 μM, and several compounds were examined for inhibitory activity against GSK-3β. Among them, 15(Z) (R 1 =H, R 2 =3-Cl-phenyl) was most active with 78% inhibition of tumor cell line (HT29) at 20 μM and 72% inhibition of GSK-3β at 20 μM.

UR - http://www.scopus.com/inward/record.url?scp=79959398638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959398638&partnerID=8YFLogxK

U2 - 10.5012/bkcs.2011.32.6.2015

DO - 10.5012/bkcs.2011.32.6.2015

M3 - Article

AN - SCOPUS:79959398638

VL - 32

SP - 2015

EP - 2020

JO - Bulletin of the Korean Chemical Society

JF - Bulletin of the Korean Chemical Society

SN - 0253-2964

IS - 6

ER -